Template:SubstanceBox/Buprenorphine
From Drugwiki
{{#arraydefine: InhaledDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: InhaledDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SmokedDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SmokedDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: OralDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: OralDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SublingualDosage |
Threshold;<=Sublingual threshold dose::0.3Sublingual dose units::mg,
Light;Sublingual min light dose::1 - Sublingual max light dose::2 mg,
Common;Sublingual min common dose::2 - Sublingual max common dose::4 mg,
Strong;Sublingual min strong dose::4 - Sublingual max strong dose::8 mg,
Heavy;Sublingual heavy dose::8mg +
}}
{{#arraydefine: SublingualDuration |
Total;Sublingual min total time::18 - Sublingual max total time::24Sublingual total time units::hours,
Onset;Sublingual min onset time::40 - Sublingual max onset time::80Sublingual onset time units::minutes,
Come up;,
Peak;Sublingual min peak time::1.5 - Sublingual max peak time::2Sublingual peak time units::hours,
Offset;,
After effects;Sublingual min afterglow time::1 - Sublingual max afterglow time::3Sublingual afterglow time units::days
}}
{{#arraydefine: BuccalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: BuccalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: InsufflatedDosage |
Threshold;< Insufflated threshold dose::0.2Insufflated dose units::mg,
Light;Insufflated min light dose::0.2 - Insufflated max light dose::0.4 mg,
Common;Insufflated min common dose::0.4 - Insufflated max common dose::0.8 mg,
Strong;Insufflated min strong dose::0.8 - Insufflated max strong dose::1.5 mg,
Heavy;Insufflated heavy dose::1.5 mg +
}}
{{#arraydefine: InsufflatedDuration |
Total;Insufflated min total time::8 - Insufflated max total time::14Insufflated total time units::hours,
Onset;Insufflated min onset time::30 - Insufflated max onset time::60Insufflated onset time units::minutes,
Come up;,
Peak;Insufflated min peak time::4 - Insufflated max peak time::8Insufflated peak time units::hours,
Offset;,
After effects;Insufflated min afterglow time::1 - Insufflated max afterglow time::3Insufflated afterglow time units::days
}}
{{#arraydefine: RectalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: RectalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: TransdermalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: TransdermalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SubcutaneousDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SubcutaneousDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: IntramuscularDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: IntramuscularDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: IntravenousDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: IntravenousDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: uncertaininteractions
| {{#ask:SubstanceBox/Buprenorphine
|?UncertainInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}}
{{#arraydefine: unsafeinteractions
| {{#ask:SubstanceBox/Buprenorphine
|?UnsafeInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}}
{{#arraydefine: dangerousinteractions
| {{#ask:SubstanceBox/Buprenorphine
|?DangerousInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}} {{#arrayprint:uncertaininteractions||@@@@|
}} {{#arrayprint:unsafeinteractions||@@@@|
}} {{#arrayprint:dangerousinteractions||@@@@|
}}
| SubstanceBox/Buprenorphine | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemical Nomenclature | |||||||||||||||||||||||||||||
| Common names | common name::Buprenex, common name::Subutex, common name::Butrans, common name::Cizdol, common name::Addnok, common name::Transtec | ||||||||||||||||||||||||||||
| Systematic name | (2S)-2-[(5R,6R,7R,14S)-9α-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol | ||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||
| Psychoactive class | psychoactive class::Opioid | ||||||||||||||||||||||||||||
| Chemical class | chemical class::Morphinan | ||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Interactions | |||||||||||||||||||||||||||||
| @@@@ | |||||||||||||||||||||||||||||
| @@@@ | |||||||||||||||||||||||||||||
| @@@@ | |||||||||||||||||||||||||||||
- ↑ Mendelson, J., Upton, R. A., Everhart, E. T., Jacob, P., Jones, R. T. (January 1997). "Bioavailability of sublingual buprenorphine". Journal of Clinical Pharmacology. 37 (1): 31–37. doi:10.1177/009127009703700106. ISSN 0091-2700.
- ↑ Eriksen, J., Jensen, N. H., Kamp-Jensen, M., Bjarnø, H., Friis, P., Brewster, D. (November 1989). "The systemic availability of buprenorphine administered by nasal spray". The Journal of Pharmacy and Pharmacology. 41 (11): 803–805. doi:10.1111/j.2042-7158.1989.tb06374.x. ISSN 0022-3573.
